Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hubei Guangji Pharma Starts Building Major Biopharma Park

publication date: Dec 9, 2009
This week, Hubei Guangji Pharmaceutical Co. Ltd. (SH: 000952) held the ceremonial laying of a foundation stone for its major new biopharmaceutical industrial park in Dajin Town, Wuxue, Hubei Province. Guangji Pharma plans to invest between 2.5 and 3 billion RMB (about $400 million) in the park over the next six to eight years. The company’s new facility will do R&D on products including vitamins, amino acids and steroid drugs. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital